CHARACTERIZATION OF THE GENETIC LANDSCAPE OF HIGH‐GRADE B‐CELL LYMPHOMA, NOS – AN LLMPP PROJECT
Brett Collinge(Spinal Cord Injury BC), David W. Scott(BC Cancer Agency), Christopher Rushton(Simon Fraser University), Giorgio Inghirami(Cornell University), Pedro Farinha, Laura K. Hilton(BC Cancer Agency), Lisa M. Rimsza(Banner - University Medical Center Tucson), Wing C. Chan(Ontario Institute for Cancer Research), Kerry J. Savage(Spinal Cord Injury BC), Dennis D. Weisenburger(University of Nebraska Medical Center), Louis M. Staudt(National Cancer Institute), Susana Ben‐Neriah(Apple (Israel)), Andreas Rosenwald(Comprehensive Cancer Center Mainfranken), Joo Y. Song(City Of Hope National Medical Center), Elı́as Campo(Hospital Clínic de Barcelona), Philipp W. Raess(Oregon Health & Science University), Timothy C. Greiner(University of Nebraska Medical Center), Christian Steidl(University of British Columbia), Andrew J. Mungall(Spinal Cord Injury BC), Graham W. Slack(BC Cancer Agency), James R. Cook(Cleveland Clinic), German Ott(Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology), C. Amador(University of Nebraska Medical Center), Klaus Beiske(Oslo University Hospital), Ryan D. Morin(Simon Fraser University), Jan Delabie, Jasper Wong, Harald Holte(Oslo University Hospital), Elaine S. Jaffe(National Cancer Institute), Kai Fu(Soochow University), Andrew L. Feldman(Mayo Clinic in Arizona), Stefania Pittaluga(New York University)
Cited by 20
Related Papers
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
|Nature|2000|9.9k
Comprehensive molecular characterization of gastric adenocarcinoma
|Nature|2014|6.5k
Nivolumab in Previously Untreated Melanoma without <i>BRAF</i> Mutation
|New England Journal of Medicine|2014|5.3k
The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma
|New England Journal of Medicine|2002|3.9k